| | | 69600 | | 04.12.2025 | | Ipsen Pharma Schweiz GmbH | | | | | | | 03.12.2030 | | | | | | | | | | 04.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Bylvay® | | | A05AX05 | CI | | 02 | Bylvay 400 μg | Hartkapseln | Capsules (Odevixibatum 400 µg, Odevixibatum Sesquihydricum 0 ) | A05AX05 | CI | | 03 | Bylvay 600 μg | Hartkapseln | Capsules (Odevixibatum 600 µg, Odevixibatum Sesquihydricum 0 ) | A05AX05 | CI | | 04 | Bylvay 1200 μg | Hartkapseln | Capsules (Odevixibatum 1.2 mg, Odevixibatum Sesquihydricum 0 ) | A05AX05 | CI |
|
|
